m smegmatis wild type strain mc (ATCC)
Structured Review

M Smegmatis Wild Type Strain Mc, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 721 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/m smegmatis wild type strain mc/product/ATCC
Average 97 stars, based on 721 article reviews
Images
1) Product Images from "Selective Pressure by Rifampicin Modulates Mutation Rates and Evolutionary Trajectories of Mycobacterial Genomes"
Article Title: Selective Pressure by Rifampicin Modulates Mutation Rates and Evolutionary Trajectories of Mycobacterial Genomes
Journal: Microbiology Spectrum
doi: 10.1128/spectrum.01017-23
Figure Legend Snippet: MA experimental evolution with increasing concentrations of rifampicin. The MA assay comprised 40 independent lines, generated from the M. smegmatis wild type and its nucS -null (Δ nucS ) mutant derivative (20 each) and evolved in parallel with increasing antibiotic concentrations. The experimental evolution was carried out for 40 weeks, from 0.25 μg mL −1 rifampicin (subinhibitory concentration) until 32 μg mL −1 rifampicin (inhibitory concentration), doubling the concentration every 5 weeks. MA lines able to grow at week 35 with 16 μg mL −1 rifampicin (18 wild type-derived and 20 Δ nucS mutant-derived) were sequenced by WGS. The figure also shows the number of lines that survived at each rifampicin concentration (below the plates) and the number of passages (black arrows). Created with BioRender.com .
Techniques Used: Generated, Mutagenesis, Concentration Assay, Derivative Assay
Figure Legend Snippet: Comparison of the mutational spectra of the MA lines evolved in the presence and absence of rifampicin. (A) Mutational spectra for M. smegmatis wild-type lines evolved with rifampicin (dark blue) and without antibiotic (light blue); (B) mutational spectra for M. smegmatis Δ nucS lines evolved in the presence (dark orange) and absence of rifampicin (light orange). Bars represent the mutation rate per nucleotide per generation for each type of DNA mutation obtained by WGS data of MA experiments from this study and our previous work . Error bars indicate 95% confidence intervals (CIs). *, P < 0.05 ( t test). t tests were complemented with Mann-Whitney U tests (see Table S5), as data for some types of mutations are nonparametric, although they are close to normality.
Techniques Used: Comparison, Mutagenesis, MANN-WHITNEY
Figure Legend Snippet: Mutations in rpoB in the MA lines: identification and effect on antibiotic resistance. (A) Types of RNAP β substitutions generated by rpoB mutations. M. smegmatis RNAP β is represented with amino acid numbering. Gray regions indicate the rifampicin resistance clusters described in E. coli ( , ). Amino acid substitutions generated by rpoB mutations in the MA lines are shown in blue (wild-type lines) and orange (Δ nucS mutant lines). Mutations associated with resistance in M. tuberculosis by the WHO catalogue are marked with asterisks. Below are shown protein alignments of RNAP β of M. smegmatis ( Msm ), M. tuberculosis ( Mtb ), and E. coli , with the amino acid positions where mutations were detected (red). (B) Effect of RNAP β substitutions on rifampicin resistance. Bars show the rifampicin MIC of the MA lines before (light purple) and after (dark purple) the acquisition of each rpoB mutation. When the rpoB mutation was present in more than one line (H442R and G450D), a representative example is shown. *, S438L substitution appeared together with V167M at the same week of the evolution.
Techniques Used: Generated, Mutagenesis

